Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amphastar Pharma
(NQ:
AMPH
)
41.11
+0.28 (+0.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amphastar Pharma
< Previous
1
2
3
4
5
6
Next >
Day One Biopharmaceuticals Stock Scores Rising Relative Strength Upgrade
June 15, 2022
Day One Biopharmaceuticals stock, which saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 83 to 92.
Via
Investor's Business Daily
69 Biggest Movers From Yesterday
June 10, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Via
Benzinga
Amphastar's Generic Ganirelix Acetate Injection Scores FDA Approval
April 08, 2022
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 09, 2022
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 09, 2022
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382.
Via
Benzinga
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
June 06, 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, and Dan Dischner, V.P of Corporate...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Small-Cap Psychedelic Play Vying for Future Leadership in Addiction Treatment (AXSM, AWKNF, BICX, OPNT, ALKS, PFE, AMPH, OMER)
June 06, 2022
Via
AB Newswire
Amphastar Pharmaceuticals's Return On Capital Employed Insights
June 02, 2022
Pulled from Benzinga Pro data, Amphastar Pharmaceuticals (NASDAQ:AMPH) posted Q1 earnings of $24.25 million, an increase from Q4 of 22.74%. Sales dropped to $120.37 million, a 0.43% decrease between...
Via
Benzinga
United Therapeutics Stock Sees RS Rating Jump To 89; Earns 'Blue Dot'
May 24, 2022
United Therapeutics stock had its Relative Strength (RS) Rating upgraded to 89 Tuesday, from 71 a day earlier.
Via
Investor's Business Daily
Amphastar Receives FDA Approval for Regadenoson
May 24, 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 24, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated New...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Exposures
Product Safety
7 Safe Small-Cap Stocks to Buy Now
May 12, 2022
If you're looking for resilient plays with high upside potential, consider these seven safe small-cap stocks to buy.
Via
InvestorPlace
Intra-Cellular Therapies Stock Clears Technical Benchmark, Hitting 90-Plus RS Rating
May 11, 2022
Intra-Cellular Therapies stock cleared a key performance benchmark, with its Relative Strength (RS) Rating, rising to 97.
Via
Investor's Business Daily
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022
May 09, 2022
Reports Net Revenues of $120.4 Million for the Three Months Ended March 31, 2022 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022
May 02, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Krystal Biotech Stock Sees Healthy Relative Strength Rating Upgrade
April 14, 2022
On Thursday, Krystal Biotech stock had its Relative Strength (RS) Rating upgraded from to 93, up 88 a day ago.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
April 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Stocks That Have Moved Over 20% Since The Indices Plummeted
April 08, 2022
The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.
Via
Benzinga
Why Top-Rated IBD 50 Stock Amphastar Pharmaceuticals Added To Its 75% Run
April 08, 2022
FDA action just sent this red-hot biotech stock to a high, continuing its strong run.
Via
Investor's Business Daily
Amphastar Receives FDA Approval for Ganirelix Acetate Injection
April 08, 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 8, 2022 / Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's Abbreviated...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Exposures
Product Safety
Sarepta Therapeutics Stock Shows Market Leadership With Jump To 85 RS Rating
April 07, 2022
On Thursdays, Sarepta Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85 from 80 a day earlier.
Via
Investor's Business Daily
Supernus Pharmaceuticals Stock Sees Relative Strength Rating Jump To 92
April 07, 2022
On Thursday, Supernus Pharmaceuticals stock earned an upgrade to its Relative Strength (RS) Rating, from 87 to 92.
Via
Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Apellis Pharmaceuticals Stock Shows Rising Relative Strength
April 04, 2022
Apellis Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, rising from 87 to 91.
Via
Investor's Business Daily
Acadia Pharmaceuticals Stock Shows Market Leadership With Jump To 91 RS Rating
March 25, 2022
Acadia Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 88 to 91.
Via
Investor's Business Daily
Biocryst Pharmaceuticals Stock Shows Rising Price Performance With Jump To 92 RS Rating
March 23, 2022
Biotech Biocryst Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 88 to 92 Wednesday.
Via
Investor's Business Daily
7 “A”-Rated Stocks to Ground Your Portfolio
March 17, 2022
It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating.
Via
InvestorPlace
Amphastar Pharmaceuticals: Q4 Earnings Insights
March 10, 2022
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021
March 10, 2022
Reports Net Revenues of $120.9 Million for the Three Months Ended December 31, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / March 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.